glp-1 average weight loss per month medications are changing the landscape of obesity treatment, but having realistic expectations is really important. Clinical trials showed weight loss of approximately: • ~15% body weight with semaglutide • ~ GLP-1 Agonists In Obesity
Description
The clinical trial numbers reflect this progression clearly
Curr Treat Options Psychiatry

Journal of Analytical Toxicology

The most common time to see side effects like these are when you initially start the medication or when you are increasing the dose

Clinical trial averages dont perfectly predict your personal outcome

doi:10.1002/14651858.CD008650.pub2
